These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33557738)

  • 21. Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review.
    Oliveira AG; Gonçalves M; Ferreira H; M Neves N
    Mult Scler Relat Disord; 2020 Feb; 38():101860. PubMed ID: 31765999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
    Wang D; Li SP; Fu JS; Bai L; Guo L
    Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.
    Mikaeili Agah E; Parivar K; Joghataei MT
    Mol Neurobiol; 2014 Apr; 49(2):625-32. PubMed ID: 23982748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
    Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
    Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases.
    Uccelli A; Laroni A; Freedman MS
    Lancet Neurol; 2011 Jul; 10(7):649-56. PubMed ID: 21683930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal Stem Cells Attenuated Blood-Brain Barrier Disruption via Downregulation of Aquaporin-4 Expression in EAE Mice.
    Liu Y; Ma Y; Du B; Wang Y; Yang GY; Bi X
    Mol Neurobiol; 2020 Sep; 57(9):3891-3901. PubMed ID: 32613467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders.
    Riazifar M; Mohammadi MR; Pone EJ; Yeri A; Lässer C; Segaliny AI; McIntyre LL; Shelke GV; Hutchins E; Hamamoto A; Calle EN; Crescitelli R; Liao W; Pham V; Yin Y; Jayaraman J; Lakey JRT; Walsh CM; Van Keuren-Jensen K; Lotvall J; Zhao W
    ACS Nano; 2019 Jun; 13(6):6670-6688. PubMed ID: 31117376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis.
    Fathollahi A; Hashemi SM; Haji Molla Hoseini M; Tavakoli S; Farahani E; Yeganeh F
    Int Immunopharmacol; 2021 Jan; 90():107207. PubMed ID: 33290966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis.
    Fransson M; Piras E; Wang H; Burman J; Duprez I; Harris RA; LeBlanc K; Magnusson PU; Brittebo E; Loskog AS
    Immunology; 2014 Jul; 142(3):431-41. PubMed ID: 24588452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal delivery of SDF-1α-preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone-induced mouse model of multiple sclerosis.
    Beigi Boroujeni F; Pasbakhsh P; Mortezaee K; Pirhajati V; Alizadeh R; Aryanpour R; Madadi S; Ragerdi Kashani I
    Cell Biol Int; 2020 Feb; 44(2):499-511. PubMed ID: 31631484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
    Rafieemehr H; Kheyrandish M; Soleimani M
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):596-604. PubMed ID: 26725557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
    Dang S; Xu H; Xu C; Cai W; Li Q; Cheng Y; Jin M; Wang RX; Peng Y; Zhang Y; Wu C; He X; Wan B; Zhang Y
    Autophagy; 2014 Jul; 10(7):1301-15. PubMed ID: 24905997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M
    Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model.
    Scruggs BA; Semon JA; Zhang X; Zhang S; Bowles AC; Pandey AC; Imhof KM; Kalueff AV; Gimble JM; Bunnell BA
    Stem Cells Transl Med; 2013 Oct; 2(10):797-807. PubMed ID: 24018793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
    Tahmasebi F; Pasbakhsh P; Barati S; Madadi S; Kashani IR
    J Cell Physiol; 2021 May; 236(5):3552-3564. PubMed ID: 32996165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
    Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
    Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation.
    Xin Y; Gao J; Hu R; Li H; Li Q; Han F; He Z; Lai L; Su M
    Immunol Lett; 2020 Sep; 225():66-73. PubMed ID: 32544469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional Profiling of Mesenchymal Stem Cells Identifies Distinct Neuroimmune Pathways Altered by CNS Disease.
    Sargent A; Shano G; Karl M; Garrison E; Miller C; Miller RH
    Int J Stem Cells; 2018 May; 11(1):48-60. PubMed ID: 29699382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
    Abramowski P; Krasemann S; Ernst T; Lange C; Ittrich H; Schweizer M; Zander AR; Martin R; Fehse B
    Stem Cells Dev; 2016 Aug; 25(15):1134-48. PubMed ID: 27250994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential use of mesenchymal stem cells for the treatment of multiple sclerosis.
    Mansoor SR; Zabihi E; Ghasemi-Kasman M
    Life Sci; 2019 Oct; 235():116830. PubMed ID: 31487529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.